Konstantinos Charizanis

Title: The Innovative Contributions of Konstantinos Charizanis

Introduction

Konstantinos Charizanis is a notable inventor based in Ypsilanti, MI (US), recognized for his significant contributions to the field of ocular treatments. With a total of six patents to his name, he has made strides in developing methods and compositions aimed at addressing various ocular disorders.

Latest Patents

Among his latest patents, Charizanis has developed innovative methods and compositions for the treatment of mydriasis. This invention provides methods, compositions, and kits containing an alpha-adrenergic antagonist, such as phentolamine, for use in monotherapy or as part of a combination therapy. These advancements are particularly beneficial for patients suffering from presbyopia, mydriasis, and other ocular disorders.

Career Highlights

Throughout his career, Charizanis has worked with prominent companies in the pharmaceutical and biotechnology sectors. Notably, he has been associated with Ocuphire Pharma, Inc. and Opus Genetics, Inc., where he has contributed to the development of innovative treatments.

Collaborations

Charizanis has collaborated with esteemed professionals in his field, including William H. Pitlick and Mina Sooch. These collaborations have further enhanced his research and development efforts in ocular therapies.

Conclusion

Konstantinos Charizanis stands out as a dedicated inventor whose work has the potential to significantly impact the treatment of ocular disorders. His innovative patents and collaborations reflect his commitment to advancing medical science.